Online Pharmacies in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Companies covered: Optum, Capsule, Walgreens, GoodRx Care, CVS Pharmacy, Amazon Pharmacy, Cost Plus Drugs, Express Scripts, Honeybee Health, PillPack (Amazon Pharmacy)

Answer Capsule

The November 2026 Online Pharmacies benchmark compares 10 companies across 542 AI answers that met its inclusion rules. Amazon Pharmacy recorded 542 mentions and 385 recommendations (71.03% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, compare the available monthly results, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

• What does the Online Pharmacies benchmark show about mentions, recommendations and placement?

Amazon Pharmacy sets the ceiling for this peer set: it appears in every benchmark answer and is endorsed in most of them, with a large share of first-place placements. That combination of reach and position makes it the reference point other online pharmacies are measured against.

The gap between being mentioned and being endorsed is where most of the competitive room sits. A brand can appear widely and still be passed over when an answer names a top choice, so proposed work should target both presence and the wording that earns an affirmative endorsement. We would build page briefs and buyer-question content around that distinction, then fact-check claims against current primary sources before any correction is queued.

What changed since last month

Questions This Section Answers

• What changed across the usable monthly Online Pharmacies snapshots?

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

The monthly figures are separate samples, so the movement between them should be read as recorded change rather than like-for-like performance. Several companies show higher recommendation rates in the latest month alongside lower mention counts, and the two movements should be described separately rather than treated as cause and effect.

Capsule and Express Scripts show the clearest upward movement in recommendation rate across the three months. Cost Plus Drugs is the exception, with both mentions and recommendations easing. Because the answer samples differ each month, none of these shifts establishes why counts or rates moved.

The usable history is therefore a directional signal, not a trend line. It is enough to justify a stable baseline going forward, with the same companies and the same inclusion rules, so later months can be compared on a consistent footing.

Company-by-company findings

Optum

Questions This Section Answers

• What measured visibility pattern and review priority does Optum have in Online Pharmacies?

Optum recorded 146 mentions (26.94%) and 109 recommendations (20.11%) across 542 answers included in the benchmark. Top 3 placements numbered 46; first-place recommendations numbered 3. Framing among its mentions was 109 positive, 37 neutral and 0 negative.

From October 2026 to November 2026, Optum's mention count fell from 157 to 146, while its recommendation count rose from 68 to 109. The recommendation rate was 10.59% and 20.11% respectively.

AI answers contained 0 conflicting claims about Optum: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://optum.com/en/pharmacy-services/medication-delivery.html.

Selected third-party review candidate: https://optumrx.com/en/.

Optum is recommended far more often than it takes first place, which suggests the answers treat it as a credible option without naming it the leading one. That is a reach story rather than a position story, and the two should be tracked separately.

We would propose a conditional review of the selected owned and third-party pages, checking current facts before any edit is suggested. The mail-order questions where Optum appears are a natural place to start a page brief.

Capsule

Questions This Section Answers

• What measured visibility pattern and review priority does Capsule have in Online Pharmacies?

Capsule recorded 107 mentions (19.74%) and 87 recommendations (16.05%) across 542 answers included in the benchmark. Top 3 placements numbered 38; first-place recommendations numbered 7. Framing among its mentions was 87 positive, 20 neutral and 0 negative.

From October 2026 to November 2026, Capsule's mention count rose from 93 to 107, while its recommendation count rose from 79 to 87. The recommendation rate was 12.31% and 16.05% respectively.

AI answers contained 3 conflicting claims about Capsule: 0 critical, 2 high, 0 medium, 1 low. Of these, 2 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://capsule.com/.

Selected third-party review candidate: https://healthrx.com/brands-capsule.

Capsule is recommended in most answers that mention it but rarely takes first place, so its strength is broad endorsement rather than top billing. The recorded conflicts about nationwide availability are the more pressing issue, since they touch directly on how the service is described.

We would propose a fact-check of those availability claims against current primary sources before any correction is considered, followed by a page brief for the selected owned page.

Walgreens

Questions This Section Answers

• What measured visibility pattern and review priority does Walgreens have in Online Pharmacies?

Walgreens recorded 372 mentions (68.63%) and 199 recommendations (36.72%) across 542 answers included in the benchmark. Top 3 placements numbered 127; first-place recommendations numbered 21. Framing among its mentions was 200 positive, 169 neutral and 3 negative.

From October 2026 to November 2026, Walgreens' mention count fell from 468 to 372, while its recommendation count rose from 172 to 199. The recommendation rate was 26.79% and 36.72% respectively.

AI answers contained 3 conflicting claims about Walgreens: 0 critical, 0 high, 2 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://walgreens.com/topic/pharmacy/prescription-delivery.jsp.

Selected third-party review candidate: https://express-scripts.com/rx.

Walgreens reaches a large share of answers and is recommended in a good portion of them, but first-place placements are comparatively few. Its visibility is strong; its position at the top of an answer is the weaker part of the picture.

The recorded conflicts concern delivery speed and store counts, both low or medium priority. We would propose verifying those details against current primary sources and folding the confirmed facts into a page brief for the selected delivery page.

GoodRx Care

Questions This Section Answers

• What measured visibility pattern and review priority does GoodRx Care have in Online Pharmacies?

GoodRx Care recorded 259 mentions (47.79%) and 152 recommendations (28.04%) across 542 answers included in the benchmark. Top 3 placements numbered 81; first-place recommendations numbered 39. Framing among its mentions was 159 positive, 100 neutral and 0 negative.

From October 2026 to November 2026, GoodRx Care's mention count rose from 198 to 259, while its recommendation count rose from 138 to 152. The recommendation rate was 21.50% and 28.04% respectively.

AI answers contained 3 conflicting claims about GoodRx Care: 0 critical, 0 high, 3 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://goodrx.com/care.

Selected third-party review candidate: https://walgreens.com/topic/virtual-healthcare.jsp.

GoodRx Care is mentioned in roughly half the answers and recommended in a meaningful share of them, with a reasonable number of first-place placements. Its reach and its position are more balanced than several peers.

The recorded conflicts concern pricing and paid-tier details, which are the kind of facts buyers check directly. We would propose a pricing fact-check against current primary sources and a page brief for the selected care page.

CVS Pharmacy

Questions This Section Answers

• What measured visibility pattern and review priority does CVS Pharmacy have in Online Pharmacies?

CVS Pharmacy recorded 409 mentions (75.46%) and 226 recommendations (41.70%) across 542 answers included in the benchmark. Top 3 placements numbered 166; first-place recommendations numbered 54. Framing among its mentions was 228 positive, 178 neutral and 3 negative.

From October 2026 to November 2026, CVS Pharmacy's mention count fell from 507 to 409, while its recommendation count rose from 203 to 226. The recommendation rate was 31.62% and 41.70% respectively.

AI answers contained 3 conflicting claims about CVS Pharmacy: 0 critical, 0 high, 1 medium, 2 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://cvs.com/content/delivery.

Selected third-party review candidate: https://rxsaver.com/blog/which-pharmacies-offer-prescription-delivery.

CVS Pharmacy is mentioned in most answers and recommended in a large share of them, with a solid number of first-place placements. It sits close to the top of the peer set on both reach and endorsement.

The recorded conflicts are minor and concern delivery timeframes and store counts. We would propose confirming those details against current primary sources and using the confirmed facts in a page brief for the selected delivery page.

Amazon Pharmacy

Questions This Section Answers

• What measured visibility pattern and review priority does Amazon Pharmacy have in Online Pharmacies?

Amazon Pharmacy recorded 542 mentions (100.00%) and 385 recommendations (71.03%) across 542 answers included in the benchmark. Top 3 placements numbered 312; first-place recommendations numbered 207. Framing among its mentions was 408 positive, 134 neutral and 0 negative.

From October 2026 to November 2026, Amazon Pharmacy's mention count fell from 602 to 542, while its recommendation count rose from 356 to 385. The recommendation rate was 55.45% and 71.03% respectively.

AI answers contained 3 conflicting claims about Amazon Pharmacy: 0 critical, 1 high, 2 medium, 0 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Another 2 possible conflicts were excluded because the company match was uncertain. They need an identity check before substantive review.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://pharmacy.amazon.com/.

Selected third-party review candidate: https://walgreens.com/topic/pharmacy/prescription-delivery.jsp.

Amazon Pharmacy appears in every benchmark answer and is recommended in most of them, with a large share of first-place placements. That is the strongest combination of reach and position in the peer set, and it makes the brand the benchmark others are compared against.

The recorded conflicts concern delivery speed and the eligible medication count for RxPass, one of them rated high priority. We would propose verifying those details against current primary sources before any correction, and a page brief for the selected owned page.

Cost Plus Drugs

Questions This Section Answers

• What measured visibility pattern and review priority does Cost Plus Drugs have in Online Pharmacies?

Cost Plus Drugs recorded 152 mentions (28.04%) and 108 recommendations (19.93%) across 542 answers included in the benchmark. Top 3 placements numbered 74; first-place recommendations numbered 15. Framing among its mentions was 116 positive, 36 neutral and 0 negative.

From October 2026 to November 2026, Cost Plus Drugs' mention count fell from 179 to 152, while its recommendation count fell from 127 to 108. The recommendation rate was 19.78% and 19.93% respectively.

AI answers contained 6 conflicting claims about Cost Plus Drugs: 0 critical, 0 high, 5 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://costplusdrugs.com/.

Selected third-party review candidate: https://medswitcher.com/blog/best-prescription-discount-programs-2026.

Cost Plus Drugs is mentioned in a moderate share of answers and recommended in most of those, though first-place placements are limited. Its mentions and recommendations both eased in the latest sample, which is worth watching without reading a cause into it.

The recorded conflicts cluster around markup and fee structure, which is central to how the service is understood. We would propose a fact-check of those fee details against current primary sources before any correction is considered.

Express Scripts

Questions This Section Answers

• What measured visibility pattern and review priority does Express Scripts have in Online Pharmacies?

Express Scripts recorded 255 mentions (47.05%) and 211 recommendations (38.93%) across 542 answers included in the benchmark. Top 3 placements numbered 116; first-place recommendations numbered 12. Framing among its mentions was 211 positive, 44 neutral and 0 negative.

From October 2026 to November 2026, Express Scripts' mention count rose from 245 to 255, while its recommendation count rose from 146 to 211. The recommendation rate was 22.74% and 38.93% respectively.

AI answers contained 0 conflicting claims about Express Scripts: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://express-scripts.com/rx.

Selected third-party review candidate: https://bcbsil.com/il/documents/rx-drugs/member-flier-mail-order-express-il.pdf.

Express Scripts is recommended in most answers that mention it, but first-place placements are few. The answers treat it as a dependable option rather than the leading one, which is a reach-and-endorsement story rather than a position story.

No conflicting claims were recorded for Express Scripts, so the work here is lighter. We would propose a page brief for the selected owned page and a check that the mail-order questions where it appears are covered clearly.

Honeybee Health

Questions This Section Answers

• What measured visibility pattern and review priority does Honeybee Health have in Online Pharmacies?

Honeybee Health recorded 107 mentions (19.74%) and 102 recommendations (18.82%) across 542 answers included in the benchmark. Top 3 placements numbered 34; first-place recommendations numbered 0. Framing among its mentions was 104 positive, 3 neutral and 0 negative.

From October 2026 to November 2026, Honeybee Health's mention count rose from 100 to 107, while its recommendation count rose from 88 to 102. The recommendation rate was 13.71% and 18.82% respectively.

AI answers contained 1 conflicting claim about Honeybee Health: 0 critical, 0 high, 1 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://honeybeehealth.com/drugs/epipen.

Selected third-party review candidate: https://forbes.com/health/wellness/best-online-pharmacies/.

Honeybee Health is recommended in nearly every answer that mentions it, but it has no first-place placements at all. That is an unusually pure form of broad endorsement without top billing, and it suggests the answers see it as a safe alternative rather than a headline choice.

The recorded conflict concerns insurance acceptance. We would propose verifying that against current primary sources and a page brief for the selected owned page.

PillPack (Amazon Pharmacy)

Questions This Section Answers

• What measured visibility pattern and review priority does PillPack (Amazon Pharmacy) have in Online Pharmacies?

PillPack (Amazon Pharmacy) recorded 115 mentions (21.22%) and 85 recommendations (15.68%) across 542 answers included in the benchmark. Top 3 placements numbered 52; first-place recommendations numbered 10. Framing among its mentions was 96 positive, 19 neutral and 0 negative.

From October 2026 to November 2026, PillPack (Amazon Pharmacy)'s mention count rose from 99 to 115, while its recommendation count rose from 74 to 85. The recommendation rate was 11.53% and 15.68% respectively.

AI answers contained 1 conflicting claim about PillPack (Amazon Pharmacy): 0 critical, 1 high, 0 medium, 0 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://pillpack.com/pharmacy-locations.

Selected third-party review candidate: https://healthvetted.com/best-online-pharmacy.

PillPack is mentioned in a moderate share of answers and recommended in most of those, with a modest number of first-place placements. Its reach is narrower than its parent brand, and the two should be tracked as separate entries rather than combined.

The recorded conflict concerns service regions and is rated high priority. We would propose verifying availability against current primary sources before any correction, and a page brief for the selected locations page.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

• What should the agency deliver when it works to establish the baseline for Online Pharmacies?

We would start by building a cohort scorecard that records each company's mentions, recommendations and placements under one consistent set of rules. The point is a traceable baseline that later months can be compared against without redefining the cohort.

The scorecard should also document how future samples will be kept comparable, including which companies are in scope and which inclusion rules apply. That record is what makes later movement interpretable rather than anecdotal.

Step 2. Verify disputed facts

Questions This Section Answers

• What should the agency deliver when it works to verify disputed facts for Online Pharmacies?

AI answers contained 23 conflicting claims across 8 companies. Another 2 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

Before any correction is proposed, the recorded conflicts need to be resolved against current primary sources. That means confirming the entity, the date and the source behind each disputed claim, and setting aside any case where the company match is uncertain.

We would keep a scoped fact-review register with an owner and an evidence requirement for each item. Confirmed edits, no-change decisions and open questions would be recorded separately so the outcome of each review is visible.

Step 3. Review owned pages

Questions This Section Answers

• What should the agency deliver when it works to review owned pages for Online Pharmacies?

The selected owned pages are candidates for review, not confirmed problems. We would prepare page briefs that state what each page needs to establish and which facts must be verified before any edit is made.

Each brief would be tied to the questions where the company actually appears, so the work responds to observed answer patterns rather than assumptions about what a page currently says.

Step 4. Review third-party sources

Questions This Section Answers

• What should the agency deliver when it works to review third-party sources for Online Pharmacies?

Third-party sources should be reviewed on their own merits before any request is made. A citation in an answer does not establish that the source influenced the answer, so the first step is to check what the page currently says and whether it is accurate.

Where a review supports a change, we would prepare an evidence-backed request package. Requests and responses would be logged separately from confirmed edits so the record stays clear.

Step 5. Address buyer questions and measure again

Questions This Section Answers

• What should the agency deliver when it works to address buyer questions and measure again for Online Pharmacies?

The observed buyer questions give us a starting point for content briefs, without treating them as search volume or proof of demand. We would draft briefs that answer those questions directly and clearly.

After that work is delivered, a fresh scorecard would be run on the same basis as the baseline. Completed work would be recorded separately from measured answer outcomes, and no gain would be claimed until the evidence supports it.

Third-party authority and citation opportunities

Questions This Section Answers

• Which cited publisher pages support targeted source review in Online Pharmacies?

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The publisher pages selected for review vary widely in how often they are cited, and citation frequency is not the same as influence on an answer. The most-cited pages are worth reviewing first, but each needs its current contents checked before any request is considered.

We would prioritize pages that cover several companies in the peer set, since a single accurate page can serve more than one review. Pages tied to a single brand come next, and each request would be backed by verified evidence rather than the citation count alone.

What we'd prioritize first

The first priority is a stable baseline, because the monthly samples differ and the current figures cannot be read as a trend without one. A cohort scorecard with fixed inclusion rules makes later comparisons meaningful.

The second priority is the fact-review register. The recorded conflicts, especially the high-priority availability claims, need primary-source verification before anything is corrected. Uncertain company matches stay outside that queue.

The third priority is page and source work, followed by buyer-question content. Each stage should record completed work separately from measured answer outcomes, so progress is visible without overstating what the evidence shows.

Methodology and conclusion

Questions This Section Answers

• What do the Online Pharmacies sample and source-review limits allow us to conclude?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 542 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5446 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison.

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

These results describe how often companies appeared and were endorsed in the captured answers, not customer satisfaction or market share. A mention and a recommendation are different measures, and placements sit inside recommendations rather than adding to them.

The monthly samples differ, so the comparisons show recorded change without establishing why it happened. The current contents of cited pages and the disputed claims still need independent verification before any correction is proposed.

The proposed next steps are a baseline scorecard, a scoped fact-review register, page and source briefs, and buyer-question content, followed by a fresh scorecard on the same basis. None of this promises a particular outcome; it creates a traceable record against which later results can be judged.